中文

Hong Kong Stocks · Free Data Page

REMEGEN 09995

REMEGEN: FY2025 revenue CN¥3.24B (+89.50% YoY); net income CN¥709.6M; 0 alerts, 2 watch items out of 17 risk checks; no TTM dividend.
Close PriceHK$70.25Day +12.31%Market CapHK$39.65BP/E5.3xTTMP/B3.83xROE (FY2025)25.4%Avg. equity

Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.

Want the full AI research report for REMEGEN?

This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.

New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.

10-Year FinancialsFY2018–2025

Financial statements are reported in CNY, while share price and market cap are quoted in HKD.

Key Multi-Year Facts

  • Revenue moved from CN¥11.3M in FY2018 to CN¥3.24B in FY2025 (7-year CAGR +124.4%).
  • Net income was negative in FY2018, FY2019, FY2020, FY2022, FY2023, FY2024.
  • Operating cash flow was below half of net income in FY2025.

Latest 5 Fiscal Years

Fiscal Year20212022202320242025
Revenue (CNY B)1.420.771.081.713.24
YoY—-46.1%40.2%58.9%89.5%
Net Income (CNY B)0.28-1.00-1.51-1.470.71
YoY—-461.6%———
Operating Cash Flow (CNY B)0.26-1.26-1.50-1.180.05
ROE7.8%-23.7%-35.9%-54.1%25.4%
Gross Margin95.3%64.8%76.5%80.0%86.9%
Net Margin19.4%-130.1%-140.4%-85.9%21.9%
Debt-to-Assets17.1%17.3%37.8%63.9%50.2%
Show all 8 fiscal years
Fiscal Year20182019202020212022202320242025
Revenue (CNY B)0.01—0.001.420.771.081.713.24
YoY————-46.1%40.2%58.9%89.5%
Net Income (CNY B)-0.27-0.43-0.700.28-1.00-1.51-1.470.71
YoY————-461.6%———
Operating Cash Flow (CNY B)-0.13-0.28-0.660.26-1.26-1.50-1.180.05
ROE——-19.4%7.8%-23.7%-35.9%-54.1%25.4%
Gross Margin21.1%——95.3%64.8%76.5%80.0%86.9%
Net Margin-2384.5%——19.4%-130.1%-140.4%-85.9%21.9%
Debt-to-Assets193.8%133.7%12.7%17.1%17.3%37.8%63.9%50.2%

Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings

Risk ChecklistAs of 2026-11-05

Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).

0Alert 2Watch 14Pass 1N/A

Items Flagged for Review

  • Watch

    Cash ConversionFinancial Quality

    OCF / Net Income: FY2025 (2025-12-31) 0.07

    FY2025 (ended 2025-12-31) · What is this?

  • Watch

    Profit WarningMaterial Events

An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.

Dividends

No dividends paid over the trailing 12 months.

Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.

More data: All research reports · Sector leaders · Market hours & holidays.

Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.